Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 24, 2018 Filed May 29, 2018 21:06 UTC GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000254 · edgar.xml · derivative · entry 2

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:06 UTC GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000254 · edgar.xml · nonDerivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,253

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:05 UTC GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000253 · edgar.xml · derivative · entry 2

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:05 UTC GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000253 · edgar.xml · nonDerivative · entry 1

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,253

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:02 UTC
Hirsch DavidDirector
GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000251 · edgar.xml · derivative · entry 4

Hirsch David · CIK 0001619884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F6 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:02 UTC
Hirsch DavidDirector
GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000251 · edgar.xml · nonDerivative · entry 1

Hirsch David · CIK 0001619884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,193

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

F2 · balance_after: Includes 24,940 shares received in distributions from Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA").

Read SEC document
May 10, 2018 Filed May 14, 2018 20:32 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 1,500 $27.00 $40,500.00
Disclosure

SEC source: 0001192482-18-000202 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 538,693

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

Read SEC document
May 10, 2018 Filed May 14, 2018 20:32 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 5,600 $26.00 $145,600.00
Disclosure

SEC source: 0001192482-18-000202 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 540,193

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

Read SEC document
May 10, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 1,400 $27.00 $37,800.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 11

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,764

F3 · kind: The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018.

Read SEC document
April 19, 2018 Filed Apr 23, 2018 21:05 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 100 $26.01 $2,601.00
Disclosure

SEC source: 0001192482-18-000165 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 545,793

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

Read SEC document
April 19, 2018 Filed Apr 23, 2018 21:05 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 44,300 $26.00 $1,151,800.00
Disclosure

SEC source: 0001192482-18-000165 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 545,893

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

Read SEC document
April 04, 2018 Filed Apr 5, 2018 17:00 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantStock Option (Right to Purchase) · Derivative 40,000 $0.00 Strike: $24.03 $0.00
Disclosure

SEC source: 0001192482-18-000154 · edgar.xml · derivative · entry 2

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2028-04-04

F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on March 16, 2019, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer.

Read SEC document
April 04, 2018 Filed Apr 5, 2018 17:00 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000154 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on March 16, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 16:50 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 3,917 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001192482-18-000151 · edgar.xml · derivative · entry 4

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,917 shares

Expires 2024-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 3,917 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vested and became exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vested in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 16:50 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 4,225 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001192482-18-000151 · edgar.xml · derivative · entry 3

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,225 shares

Expires 2024-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 4,225 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vested and became exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 16:50 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 3,917 $0.28 $1,096.76
Disclosure

SEC source: 0001192482-18-000151 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,458

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2018 Filed Apr 4, 2018 16:50 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 4,225 $0.28 $1,183.00
Disclosure

SEC source: 0001192482-18-000151 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,541

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 19, 2018 Filed Mar 21, 2018 23:58 UTC OtherCommon Stock 8,791 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000131 · edgar.xml · nonDerivative · entry 2

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By John Freund Family Partnership IV, L.P.

Disclosed balance after: 20,506

F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to the reporting person.

F4 · ownership.nature: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.

Read SEC document
March 19, 2018 Filed Mar 21, 2018 23:58 UTC OtherCommon Stock 600,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000131 · edgar.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Skyline Venture Partners V, L.P.

Disclosed balance after: 1,549,916

F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners.

F2 · ownership.nature: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 16:03 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 1,193 $21.77 $25,971.61
Disclosure

SEC source: 0001192482-18-000097 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,316

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 21:04 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
Tax withholdingCommon Stock 4,050 $21.77 $88,168.50
Disclosure

SEC source: 0001192482-18-000099 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 590,193

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 26, 2018 Filed Mar 1, 2018 21:03 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 1,197 $21.77 $26,058.69
Disclosure

SEC source: 0001192482-18-000098 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,436

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 05, 2018 Filed Feb 6, 2018 16:16 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 214 $23.38 $5,003.32
Disclosure

SEC source: 0001192482-18-000076 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,509

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 05, 2018 Filed Feb 6, 2018 21:14 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
Tax withholdingCommon Stock 788 $23.38 $18,423.44
Disclosure

SEC source: 0001192482-18-000074 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,243

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
February 05, 2018 Filed Feb 6, 2018 21:18 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 214 $23.38 $5,003.32
Disclosure

SEC source: 0001192482-18-000078 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,633

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
January 26, 2018 Filed Jan 30, 2018 00:41 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
GrantCommon Stock 1,044 $10.17 $10,617.48
Disclosure

SEC source: 0001192482-18-000067 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 595,031

F2 · kind: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
January 26, 2018 Filed Jan 30, 2018 00:38 UTC
Brannelly PaulExecutive Vice President & CFO
GrantCommon Stock 1,044 $10.17 $10,617.48
Disclosure

SEC source: 0001192482-18-000063 · edgar.xml · nonDerivative · entry 3

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,847

F2 · kind: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
January 25, 2018 Filed Jan 29, 2018 19:37 UTC
Fleming Alison BChief Technology Officer
GrantStock Option (Right to Purchase) · Derivative 50,000 $0.00 Strike: $24.35 $0.00
Disclosure

SEC source: 0001192482-18-000061 · edgar.xml · derivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-01-25

F2 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2018 Filed Jan 29, 2018 19:37 UTC
Fleming Alison BChief Technology Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000061 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,723

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock.

Read SEC document
January 25, 2018 Filed Jan 30, 2018 00:41 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
GrantStock Option (Right to Purchase) · Derivative 150,000 $0.00 Strike: $24.35 $0.00
Disclosure

SEC source: 0001192482-18-000067 · edgar.xml · derivative · entry 3

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2028-01-25

F3 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2018 Filed Jan 30, 2018 00:41 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000067 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 593,987

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock.

Read SEC document
January 25, 2018 Filed Jan 30, 2018 00:39 UTC
Ciaffoni JosephChief Operating Officer
GrantStock Option (Right to Purchase) · Derivative 50,000 $0.00 Strike: $24.35 $0.00
Disclosure

SEC source: 0001192482-18-000065 · edgar.xml · derivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-01-25

F2 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2018 Filed Jan 30, 2018 00:39 UTC
Ciaffoni JosephChief Operating Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000065 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,268

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock.

Read SEC document
January 25, 2018 Filed Jan 30, 2018 00:38 UTC
Brannelly PaulExecutive Vice President & CFO
GrantStock Option (Right to Purchase) · Derivative 50,000 $0.00 Strike: $24.35 $0.00
Disclosure

SEC source: 0001192482-18-000063 · edgar.xml · derivative · entry 4

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2028-01-25

F3 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2018 Filed Jan 30, 2018 00:38 UTC
Brannelly PaulExecutive Vice President & CFO
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000063 · edgar.xml · nonDerivative · entry 2

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,803

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock.

Read SEC document
January 23, 2018 Filed Jan 23, 2018 22:41 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommn Stock 16,408 $25.01 $410,364.08
Disclosure

SEC source: 0001192482-18-000054 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 518,987

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2018 Filed Jan 23, 2018 22:41 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 3,592 $25.00 $89,800.00
Disclosure

SEC source: 0001192482-18-000054 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 535,395

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

Read SEC document
January 19, 2018 Filed Jan 19, 2018 22:41 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 20,000 $22.50 $450,000.00
Disclosure

SEC source: 0001192482-18-000046 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 538,987

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.50 to $22.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 19, 2018 Filed Jan 11, 2021 17:06 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 3,336 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0001192482-21-000050 · edgar.xml · derivative · entry 5

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,042

Underlying: Common Stock · 3,336 shares

Expires 2025-03-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: At the time of exercise, 3,336 shares under the option were exercisable. The option, initially representing a right to purchase a total of 60,378 shares, vested and became exercisable over a four-year period commencing on March 19, 2015. The option vested and became exercisable in equal installments (rounded up to the nearest whole share) on a monthly basis over a four-year period commencing on March 19, 2015, subject to the employee's continued service with the issuer.

Read SEC document
January 19, 2018 Filed Jan 11, 2021 17:06 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 3,336 $23.00 $76,728.00
Disclosure

SEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,419

F2 · kind: The sales occurring on January 19, 2018 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
January 19, 2018 Filed Jan 11, 2021 17:06 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 3,336 $5.73 $19,115.28
Disclosure

SEC source: 0001192482-21-000050 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,755

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: The transactions reported in this Form 4 occurring on January 19, 2018 are late due to an administrative error.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 1,449 $0.00 Strike: $3.31 $0.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 17

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,449 shares

Expires 2021-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option was fully vested and exercisable as of January 19, 2018.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 1,811 $0.00 Strike: $0.90 $0.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 16

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,811 shares

Expires 2020-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option was fully vested and exercisable as of January 19, 2018.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 64 $0.00 Strike: $0.90 $0.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 15

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64 shares

Expires 2019-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option was fully vested and exercisable as of January 19, 2018.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 1,449 $23.00 $33,327.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 10

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,164

F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionCommon Stock 1,449 $3.31 $4,796.19
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 9

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,613

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 1,811 $23.00 $41,653.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 8

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,164

F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionCommon Stock 1,811 $0.90 $1,629.90
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 7

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,975

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 64 $23.00 $1,472.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 6

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,164

F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
January 19, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionCommon Stock 64 $0.90 $57.60
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 5

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.